Is Short-Term Semaglutide Right for Your Weight Loss Plan Short-term semaglutide therapy makes sense if you have 15% to 30% excess body weight to lose, can commit to behavioral changes during treatment, and prefer a defined treatment window over indefinite medication use
The DPP-4 inhibitor trials exemplify this disparity
That is why we are at ADA 2026to talk to patients, health care professionals, and investors to present our data but also listen and learn." This year, more patients starting a new weight management therapy have filled prescriptions for Wegovy than any other available obesity medication
Adults with Type 2 diabetes who have not achieved adequate blood sugar control through diet, exercise, oral medications, or other non-insulin therapies
Book a BodySpec DEXA scan to track changes in lean mass, fat mass, and visceral fat